NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
August 15, 2024 — CSD receives $250,000 award from PCORI to improve virtual healthcare access for the Deaf community. The project aims to empower the Deaf community by incorporating diverse lived experiences to drive community-centered change for improved health outcomes.
August 14, 2024 — SOBRsafe reports on NASDAQ listing exception, financial positioning, and sales growth, highlighting the company's innovative alcohol-detection technology and its potential impact on healthcare markets.
August 14, 2024 — Oncolytics Biotech's pelareorep demonstrates promising results in the treatment of metastatic breast cancer, offering hope to patients and potential investors alike.
August 14, 2024 — Clean Beauty Awards 2025: Call for Entries for Safer Skincare Products
August 14, 2024 — New report from ADAP Advocacy and CANN highlights the 340B Program's impact on executive compensation and charity care provision. The findings urge a reevaluation of the program's priorities to better serve patients.
August 13, 2024 — Annovis Bio (ANVS) secures U.S. patent for treating traumatic brain injury (TBI) with buntanetap, a potential breakthrough in TBI treatment and neurodegenerative diseases.
August 13, 2024 — Clene Inc. presents new findings and information about its lead drug candidate, CNM-Au8, at the recent Emerging Growth Conference 73, showcasing progress in addressing neurodegenerative conditions.
August 13, 2024 — Clene Inc. presents new findings and information about the company and its lead drug candidate CNM-Au8 at the Emerging Growth Conference 73, showcasing significant strides in developing potential treatments for neurodegenerative diseases.
August 13, 2024 — PathAI introduces AIM-MASH, an AI-based measurement tool, to support precise and reproducible MASH assessments. The launch of AIM-MASH on AISight IMS addresses a crucial gap in pathology labs, providing digital and AI tools to assist pathologists in making accurate assessments at scale.
August 13, 2024 — Safety Shot, Inc. revolutionizes responsible alcohol consumption with its flagship drink, backed by scientific research and strategic partnerships. The company's innovative approach offers a potential solution for managing the effects of alcohol consumption, redefining wellness and responsible drinking.
August 13, 2024 — Resonance Sports Acupuncture expands to a new location in Golden, Colorado, offering comprehensive care for athletes and active individuals.
August 13, 2024 — XpertDox partners with QuickVisit Urgent Care to optimize revenue cycle and streamline medical coding processes in underserved communities.
August 12, 2024 — Jet Jockeys host, Brett Vance, discusses the growing concerns around COVID-19 vaccine injuries and their impact on flight crews and aviation safety. He urges those affected to seek treatment and recover their health.
August 12, 2024 — Alzamend Neuro, Inc. and Massachusetts General Hospital collaborate on Phase II trials of AL001 for MDD, bipolar disorder, and Alzheimer’s, aiming to enhance treatment effectiveness and safety. The news also covers Alzamend Neuro, Inc.'s $25 million funding to advance clinical trials for several neurological and psychiatric disorders.
August 12, 2024 — Benchmark International unveils its 2024 Global Healthcare & Medical Industry Report, offering valuable insights into current trends, challenges, and opportunities within the healthcare and medical sectors.
August 12, 2024 — Therma Bright Inc. is at the forefront of the expanding medical devices market, with significant advancements and strategic investments positioning the company for growth and transformative success.
August 11, 2024 — TexasPlans.com releases comprehensive guide for Texas residents to navigate Health Exchange subsidy income chart, maximize subsidies, and reduce healthcare costs.
August 10, 2024 — Amerigo Scientific announces the availability of its comprehensive range of glycan standards for analytical applications. These products are crucial for maintaining consistency and accuracy in glycan analysis data, offering researchers a valuable resource for their studies.
August 9, 2024 — Annovis Bio reports new preclinical data on buntanetap, its lead compound, showing a synergistic effect when combined with the GLP-1 agonist dulaglutide in a mouse model of Alzheimer’s disease. The company's innovative approach addresses neurodegenerative disorders like Alzheimer’s and Parkinson’s, with the potential to transform treatment and impact millions of patients worldwide.
August 9, 2024 — Clene (NASDAQ: CLNN) featured in BioMedWire Podcast, CEO discusses unique approach to treating neurodegenerative diseases such as ALS and MS, highlighting potential for improved patient survival rates.